Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Paciotti

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|February 27, 2020
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's DiseaseSilvia Paciotti, Elisabetta Albi, Lucilla Parnetti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 30, 2019
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathiesSilvia Paciotti, Leonardo Gatticchi, Tommaso Beccari, et al.
Frontiers in Neurology|June 22, 2018
Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic ToolsSilvia Paciotti, Giovanni Bellomo, Leonardo Gatticchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2019
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunctionGiovanni Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2014
Lysosomal enzymes in PD: further evidence is neededDavide Chiasserini, Emanuele Persichetti, Silvia Paciotti, et al.
Expert Review of Molecular Diagnostics|June 13, 2017
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's diseaseLucia Farotti, Silvia Paciotti, Anna Tasegian, et al.
Alzheimer'S Research & Therapy|September 30, 2020
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?Giovanni Bellomo, Samuela Cataldi, Silvia Paciotti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 4, 2019
Parkinson's and Lewy body dementia CSF biomarkersLucilla Parnetti, Silvia Paciotti, Lucia Farotti, et al.
Frontiers in Bioscience (Landmark Edition)|December 3, 2021
Seed amplification assays for diagnosing synucleinopathies: the issue of influencing factorsGiovanni Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 18, 2019
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosisSilvia Paciotti, Federica N Sepe, Paolo Eusebi, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|February 27, 2020
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's DiseaseSilvia Paciotti, Elisabetta Albi, Lucilla Parnetti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 30, 2019
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathiesSilvia Paciotti, Leonardo Gatticchi, Tommaso Beccari, et al.
Frontiers in Neurology|June 22, 2018
Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic ToolsSilvia Paciotti, Giovanni Bellomo, Leonardo Gatticchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2019
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunctionGiovanni Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2014
Lysosomal enzymes in PD: further evidence is neededDavide Chiasserini, Emanuele Persichetti, Silvia Paciotti, et al.
Expert Review of Molecular Diagnostics|June 13, 2017
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's diseaseLucia Farotti, Silvia Paciotti, Anna Tasegian, et al.
Alzheimer'S Research & Therapy|September 30, 2020
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?Giovanni Bellomo, Samuela Cataldi, Silvia Paciotti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 4, 2019
Parkinson's and Lewy body dementia CSF biomarkersLucilla Parnetti, Silvia Paciotti, Lucia Farotti, et al.
Frontiers in Bioscience (Landmark Edition)|December 3, 2021
Seed amplification assays for diagnosing synucleinopathies: the issue of influencing factorsGiovanni Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 18, 2019
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosisSilvia Paciotti, Federica N Sepe, Paolo Eusebi, et al.
Pageof 4